Arch Biopartners Inc (ARCH) NPV
Sell:1.74 CADBuy:1.75 CAD
0.01 CAD
(0.57%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:1.74 CAD
Buy:1.75 CAD
Change:0.01 CAD
(0.57%)
0.01 CAD
(0.57%)Prices delayed by at least 15 minutes
Sell:1.74 CAD
Buy:1.75 CAD
Change:0.01 CAD
(0.57%)
0.01 CAD
(0.57%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 10 April 2025 | Richard Gabriel MuruveChairman/CEO | Buy Regular purchase transaction | 1,200 | 1.81 CAD | 2,172.00 CAD | 9,241,010 |
| 9 April 2025 | Richard Gabriel MuruveChairman/CEO | Buy Regular purchase transaction | 400 | 1.75 CAD | 698.00 CAD | 9,239,810 |
| 9 April 2025 | Richard Gabriel MuruveChairman/CEO | Buy Regular purchase transaction | 11,100 | 1.75 CAD | 19,410.57 CAD | 9,239,410 |
| 9 April 2025 | Richard Gabriel MuruveChairman/CEO | Buy Regular purchase transaction | 2,000 | 1.64 CAD | 3,280.00 CAD | 9,228,310 |
| 9 April 2025 | Richard Gabriel MuruveChairman/CEO | Buy Regular purchase transaction | 4,000 | 1.65 CAD | 6,600.00 CAD | 9,226,310 |
| 9 April 2025 | Richard Gabriel MuruveChairman/CEO | Buy Regular purchase transaction | 2,100 | 1.65 CAD | 3,465.00 CAD | 9,222,310 |
| 9 April 2025 | Richard Gabriel MuruveChairman/CEO | Buy Regular purchase transaction | 3,500 | 1.64 CAD | 5,740.00 CAD | 9,220,210 |
| 11 March 2025 | Richard Gabriel MuruveChairman/CEO | Buy Regular purchase transaction | 400 | 1.73 CAD | 691.20 CAD | 9,216,710 |
| 7 February 2025 | Richard Gabriel MuruveChairman/CEO | Sell Regular sell transaction (market) | 5,000 | 1.89 CAD | 9,450.00 CAD | 9,216,310 |
| 16 January 2025 | Richard Gabriel MuruveChairman/CEO | Buy Regular purchase transaction | 200 | 1.93 CAD | 386.00 CAD | 9,221,310 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 21 June 2024 | Andrew Trevor BishopDirector | Sell Option/Award related | 100,000 | 1.72 CAD | 172,000.00 CAD | 380,000 |
| 22 May 2024 | Richard Gabriel MuruveChairman/CEO | Buy Regular purchase transaction | 85,714 | 1.75 CAD | 149,999.50 CAD | 9,006,810 |
| 21 May 2024 | Daniel Abraham MuruvePresident | Sell Regular sell transaction (market) | 85,714 | 1.75 CAD | 149,999.50 CAD | 2,047,619 |
| 9 April 2025 | Richard Gabriel MuruveChairman/CEO | Buy Regular purchase transaction | 11,100 | 1.75 CAD | 19,410.57 CAD | 9,239,410 |
| 24 October 2024 | Richard Gabriel MuruveChairman/CEO | Sell Regular sell transaction (market) | 5,000 | 2.06 CAD | 10,300.00 CAD | 492,000 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.